Opinion: People with serious illness can teach us a lot about living with Covid-19
As the U.S. grapples with a potentially deadly pandemic, it can learn a lot from…
Category: Biotech
When might experimental drugs to treat Covid-19 be ready? A forecast
There is a desperate need for new medicines to treat Covid-19, the disease caused by…
Desperate for Covid-19 answers, U.S. doctors turn to colleagues in China
Even as the Covid-19 outbreak has already overwhelmed some U.S. hospitals, in many cities anxious…
STAT Plus: Despite investments and advocacy, pharma’s still making its drugs in batches that can take months — rather than continuously. Why?
WASHINGTON — Former FDA Commissioner Scott Gottlieb said so-called continuous manufacturing would prevent drug shortages,…
‘A long ways from everything’: In Montana, distance is shaping the coronavirus response
BUTTE, Mont. — The little town of Libby, a former mining hub of 2,700 that’s…
Doctors warn an inability to smell could be a symptom of Covid-19 — but caution the evidence is preliminary
Health care workers are calling attention to a potential new symptom of a novel coronavirus…
As coronavirus spreads, thousands of foreign doctors could be blocked from U.S. entry, group warns
The status of 7,000 foreign doctors who were chosen to do medical residencies in American…
Opinion: Antibiotic resistance: the hidden threat lurking behind Covid-19
The ongoing Covid-19 pandemic highlights the critical need for rapid development of vaccines and antiviral…
Ecuador becomes the latest country to eye compulsory licensing for Covid-19 products
As the novel coronavirus continues to spread, Ecuador has become the latest country in which…
STAT Plus: An Indian drug maker is slammed by FDA for tossing ‘cartloads of trash bags’ filled with documents
Amid global anxiety over the novel coronavirus, a newly issued warning letter by the Food…
STAT Plus: AbbVie waives all worldwide restrictions on making generic copies of its Kaletra HIV pill
In an unexpected development, AbbVie (ABBV) is waiving restrictions on licenses held by a nonprofit…
STAT Plus: Startup Spotlight: Carisma Therapeutics wants to make a cell therapy that will work in solid tumors
When Michael Klichinsky was rotating through University of Pennsylvania hospitals as a pharmacy student more…
Opinion: What Singapore can teach the U.S. about responding to Covid-19
Our country, Singapore, has managed to contain the spread of the SARS-CoV-2 virus within its…
STAT Plus: Pharmalittle: Researchers identify 70 drugs for possibly fighting Covid-19; Gilead pauses access to experimental drug
Good morning, everyone, and how are you today? We hope the weekend break was something…
As Covid-19 spreads, disruptions to clinical trial and drug development accelerate
The disruption of clinical trials due to the novel coronavirus pandemic is becoming an almost…
Opinion: The white scarf on the door: a life-saving lesson from the 1918 Spanish flu
In 1918, a white scarf tied to the door of my grandmother’s family’s apartment on…
Opinion: Covid-19 is reshaping the world of bioscience publishing
The Covid-19 pandemic is rapidly changing our lives in previously unimaginable ways and forcing us…
I asked eight chatbots whether I had Covid-19. The answers ranged from ‘low’ risk to ‘start home isolation’
U.S. hospitals, public health authorities, and digital health companies have quickly deployed online symptom checkers…
For people with underlying health conditions, the coronavirus presents ‘all the ingredients’ for danger
An infection from the coronavirus can be a formidable threat to anyone. But it is…
Why President Trump is at odds with his medical experts over using malaria drugs against Covid-19
One of the most wrenching questions in medicine has been playing out to garish effect…
Gilead suspends access to experimental Covid-19 drug due to ‘overwhelming demand’
Gilead Sciences has temporarily stopped granting patients access to remdesivir, its experimental drug against the…
As public hungers for coronavirus tests, FDA warns new at-home kits are ‘unauthorized’
As a wave of at-home tests for coronavirus are coming on the market, federal regulators…
New coronavirus test returns results in 45 minutes, but it may be limited to hospitals
A new diagnostic test for the novel coronavirus will return results in just 45 minutes,…
A plea from doctors in Italy: To avoid Covid-19 disaster, treat more patients at home
A dozen physicians at the epicenter of Italy’s Covid-19 outbreak issued a plea to the…
.jpg)
Opinion: We don’t send soldiers to fight a war without weapons. Give doctors what they need to fight Covid-19
My husband has been an emergency physician for 30 years. During that time, I have…
Opinion: I fought Ebola. Here’s my advice for health workers fighting Covid-19
In the summer of 2014, as I was preparing to fly to West Africa as…
.jpg)
STAT Plus: Congress’s coronavirus stimulus package contains plenty of unrelated wins for the health industry
WASHINGTON — A $1 trillion stimulus proposal unveiled Thursday evening by Senate Majority Leader Mitch…
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
After the Israeli government approved licensing for a generic copy of the Kaletra HIV pill…
Trump says his belief in one potential coronavirus drug is ‘just a feeling’
WASHINGTON — President Trump on Friday admitted that his enthusiasm for an antimalarial drug unproven…
At-home tests for coronavirus are here. Should you take them?
With delays in testing hampering the country’s ability to accurately track the new coronavirus and…
STAT Plus: Pfizer’s top-selling vaccine won’t prevent Covid-19, but could get a boost because of it
Vaccines tend to get a bad reputation among biotech investors. Which makes it easy to…
STAT Plus: Pharmalittle: Trump adviser slams PhRMA pushback against ‘American-made’; drug makers boost production of malaria pill for Covid-19
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Testing medical students is big business. I see it as extortion
On Friday, I’ll be one of thousands of medical students nervously waiting for the results…
Opinion: A chronic illness conundrum: Should I tell my employer about my MS?
As I prepared to tell my employer that I have relapsing remitting multiple sclerosis, I…
Opinion: A new self-triage tool can help you decide if you need medical care for Covid-19
If you have a cough, fever, or shortness of breath, how can you tell if…
‘A lose-lose situation’: Assisted living residents may see lapses in care during pandemic
Every day, a quiet army of aides fans out across the country to fight off…
The coronavirus is imperiling drug studies. A virtual study of the Apple Watch could be positioned to thrive
A highly anticipated heart study of the Apple Watch is facing disruptions as a result…
‘A number of new stars’: The definitive guide to the Trump administration’s coronavirus response team
WASHINGTON — Vice President Mike Pence is in charge of the Trump administration’s response to…
Understanding what works: How some countries are beating back the coronavirus
With Europe and the United States locked in deadly battle with the coronavirus that causes…
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Two manufacturers of a decades-old malaria drug that some research has suggested may be useful…
Listen: Trump’s coronavirus pivot, life inside the ICU, drug development in a pandemic
Why did the U.S. change its tune on coronavirus? What’s it like to be an…
A drug maker recently doubled the price of chloroquine — but in response to the coronavirus pandemic, it’s cutting it in half
WASHINGTON — A company that makes a medication increasingly touted as a promising coronavirus treatment,…
With the coronavirus surging, Trump wants drug development to move far faster. It can’t
For about 20 minutes on Thursday, President Trump undermined six decades of dogma on the…
STAT Plus: Preventing other Shkreli-like debacles may not save the government much money
After Martin Shkreli took a 5,000% price hike on a decades-old medicine and thwarted rivals,…
STAT Plus: ‘Organ-on-a-chip’ maker Emulate names new CEO, announces new funding
A Boston startup known for its plastic chips that simulate human organs announced the appointment…
An updated guide to the coronavirus drugs and vaccines in development
In the months since the novel coronavirus rose from a regional crisis to a global…
Drug makers are racing to develop immune therapies for Covid-19. Will they be ready in time?
In the 1995 movie “Outbreak,” doctors whip up a serum from monkey blood in just…
STAT Plus: Biotech in the time of the coronavirus: Disruptions continue, but there’s some good news, too
Back again with another semi-regular column on the Covid-19 pandemic. You can read my first…
STAT Plus: Pharmalittle: WHO to launch expansive coronavirus clinical trial; FDA halts some domestic inspections
Rise and shine, everyone, another intense day is on the way. The world seems to…
Opinion: Telehealth overpromises during the Covid-19 pandemic
“No more germy waiting rooms.” That’s the pitch from telehealth companies as we face the…